Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE Heterozygous activating mutations in the KCNJ11 gene encoding the pore-forming Kir6.2 subunit of the pancreatic beta cell K(ATP) channel are the most common cause of permanent neonatal diabetes (PNDM). 17668386 2007
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease UNIPROT A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit. 17855752 2007
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease CLINVAR Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism. 18250167 2008
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 Biomarker disease BEFREE Molecular analysis of chromosome 6 anomalies and the KCNJ11 and ABCC8 genes encoding Kir6.2 and SUR1 provides a tool for distinguishing transient from permanent neonatal diabetes mellitus in the neonatal period. 18279778 2008
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE Mutations in KCNJ11, ABCC8, or INS are the cause of permanent neonatal diabetes mellitus in about 50% of patients diagnosed with diabetes before 6 months of age and in a small fraction of those diagnosed between 6 and 12 months. 18662362 2008
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene. 19169493 2008
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE We report a novel KCNJ11 mutation causing PNDM. 19351728 2009
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease UNIPROT Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms. 20022885 2010
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE In summary, the switch from insulin therapy to SU treatment in PNDM related to KCNJ11 mutations was found to be an efficient and safe therapeutic method over a period of 34-month median follow-up. 20184447 2010
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancy. 20466780 2010
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE We report a 3-year-old girl with permanent neonatal diabetes (PNDM) caused by a novel heterozygous mutation (K185Q) at residue K185 of KCNJ11. 20546268 2010
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease CLINVAR ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. 20685672 2010
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE Although PNDM is a rare phenomenon (one case in about 200,000 live births), this discovery has had a large impact on clinical practice as most carriers of KCNJ11 and ABCC8 gene mutations have been switched from insulin to oral sulphonylureas with an improvement in glycemic control. 21054355 2011
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients. 21352428 2011
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease CLINVAR Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism. 21422196 2011
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease CLINVAR Abstracts of the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism. Geneva, Switzerland. August 30-September 2, 2011. 21812132 2011
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE Mutations in KCNJ11, ABCC8, or INS are the cause of permanent neonatal diabetes mellitus in about 50%-60% of the patients. 21823539 2011
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GermlineCausalMutation disease ORPHANET Review on monogenic diabetes. 21844708 2011
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE We report a 18-month follow-up of switching from insulin to SU in a mother and her daughter with PNDM due to KCNJ11 mutation. 21871684 2011
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE Permanent neonatal diabetes mellitus (PNDM) in European population has an incidence of at least 1 in 260 000 live births and is most commonly due to mutations in KCNJ11 and ABCC8. 22060631 2012
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE In the present study, we sequenced the KCNJ11 gene in a Chinese boy diagnosed with permanent neonatal diabetes mellitus (PNDM) and also in his parents. 22145471 2011
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease CLINVAR Role of Derlin-1 protein in proteostasis regulation of ATP-sensitive potassium channels. 22311976 2012
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GermlineCausalMutation disease ORPHANET The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis. 22498247 2012
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE Gain-of-function mutations of KCNJ11 can cause permanent neonatal diabetes mellitus, but only rarely after 6 months of age. 22694282 2012
DIABETES MELLITUS, PERMANENT NEONATAL
1.000 GeneticVariation disease BEFREE We describe a 12-year-old Portuguese girl with PNDM due to the previously reported R201C mutation in the KCNJ11 gene. 22768671 2012